Press Release
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) and Nippon Life Insurance Company (Head Office: Osaka, Japan; President: Satoshi Asahi; “Nissay”) announce that they have agreed to collaborate in the field of healthcare.
Going forward, the two companies will combine their respective assets and begin joint research into the development of disease risk assessment models for chronic diseases, cancer, and other conditions that utilize data held by Nissay.
Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalized medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and co-creation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives. For more information about Sysmex, please visit www.sysmex.co.jp/en/. |
|